A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

被引:0
|
作者
Praveen J Patel
Catey Bunce
Adnan Tufail
机构
[1] Moorfields Eye Hospital,
来源
Trials | / 9卷
关键词
Visual Acuity; Bevacizumab; Optical Coherence Tomography; Ranibizumab; Well Correct Visual Acuity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study
    Marques, Joao Pedro
    Farinha, Claudia
    Costa, Miguel Angelo
    Ferrao, Angela
    Nunes, Sandrina
    Silva, Rufino
    BMJ OPEN, 2017, 7 (08):
  • [32] Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
    Heier, Jeffrey S.
    Lad, Eleonora M.
    Holz, Frank G.
    Rosenfeld, Philip J.
    Guymer, Robyn H.
    Boyer, David
    Grossi, Federico
    Baumal, Caroline R.
    Korobelnik, Jean-Francois
    Slakter, Jason S.
    Waheed, Nadia K.
    Metlapally, Ravi
    Pearce, Ian
    Steinle, Nathan
    Francone, Anibal A.
    Hu, Allen
    Lally, David R.
    Deschatelets, Pascal
    Francois, Cedric
    Bliss, Caleb
    Staurenghi, Giovanni
    Mones, Jordi
    Singh, Rishi P.
    Ribeiro, Ramiro
    Wykoff, Charles C.
    LANCET, 2023, 402 (10411): : 1434 - 1448
  • [33] Photodynamic therapy with verteporfin of predominantly classic subfoveal choroidal neovascularization secondary to age-related macular degeneration: evaluation of the efficacy and safety in the VIT study.
    Maestroni, L
    Ottochian, M
    Staurenghi, G
    Orzalesi, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S439 - S439
  • [34] A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration
    Nowak, Michal S.
    Jurowski, Piotr
    Grzybowski, Andrzej
    Gos, Roman
    Pastuszka, Miroslaw
    Kapica, Andrzej
    Smigielski, Janusz
    MEDICAL SCIENCE MONITOR, 2012, 18 (06): : CR374 - CR380
  • [35] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial
    Mitchell, Paul
    Holz, Frank G.
    Hykin, Philip
    Midena, Edoardo
    Souied, Eric
    Allmeier, Helmut
    Lambrou, George
    Schmelter, Thomas
    Wolf, Sebastian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (09): : 1911 - 1920
  • [36] EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
    Jialiang Zhao
    Xiaoxin Li
    Shibo Tang
    Gezhi Xu
    Xun Xu
    Feng Zhang
    Meixia Zhang
    Jila Shamsazar
    Stefan Pilz
    Annette Nieweg
    BioDrugs, 2014, 28 : 527 - 536
  • [37] EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
    Zhao, Jialiang
    Li, Xiaoxin
    Tang, Shibo
    Xu, Gezhi
    Xu, Xun
    Zhang, Feng
    Zhang, Meixia
    Shamsazar, Jila
    Pilz, Stefan
    Nieweg, Annette
    BIODRUGS, 2014, 28 (06) : 527 - 536
  • [38] Safety and efficacy results of ONS-5010, an ophthalmic bevacizumab from the Norse TWO Phase 3 study of monthly intravitreal ONS-5010 in subjects with wet age-related macular degeneration
    Lee, Lawrence
    Hu, Allen
    Brown, Jeremiah
    Humayun, Mark
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 828 - 829
  • [39] APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
    Cohen, Michael N.
    O'Shaughnessy, Denis
    Fisher, Kate
    Cerami, Jennifer
    Awh, Carl C.
    Salazar, Daniel E.
    Rosenfeld, Philip
    Heier, Jeffrey S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (05) : 716 - 722